VolitionRX Limited (VNRX) financial statements (2023 and earlier)

Company profile

Business Address 13215 BEE CAVE PARKWAY
AUSTIN, TX 78738
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,58119,44516,96613,42710,11621,6795,916
Cash and cash equivalents20,58119,44516,96613,42710,11621,6795,916
Receivables137     
Prepaid expense598303268245249166153
Other current assets787577323230202167154
Total current assets:21,97920,33217,55613,90210,56722,0126,223
Noncurrent Assets
Finance lease, right-of-use asset  (41)
Operating lease, right-of-use asset384326381
Property, plant and equipment4,9115,1712,9813,1203,4812,119784
Intangible assets, net (including goodwill)217322372467576602705
Intangible assets, net (excluding goodwill)217322372467576602705
Other undisclosed noncurrent assets  41    
Total noncurrent assets:5,5125,8193,7353,5874,0572,7211,489
TOTAL ASSETS:27,49026,15121,29117,48914,62424,7337,712
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,3835,0312,7961,7301,630281712
Accounts payable1,5421,540627807352  
Accrued liabilities3,8413,4922,1699231,2781,439 
Other undisclosed accounts payable and accrued liabilities     (1,158)712
Debt7981,0811,0034174443181
Deferred revenue and credits 46219
Other undisclosed current liabilities335124611862161,676107
Total current liabilities:6,5166,2373,8602,3332,2902,0331,120
Noncurrent Liabilities
Long-term debt and lease obligation2,7823,3612,9351,9841,313432 
Long-term debt, excluding current maturities2,2712,6072,1951,9841,313432 
Finance lease, liability511602608
Operating lease, liability 152132
Other undisclosed noncurrent liabilities4712602981,0311,0631,092548
Total noncurrent liabilities:3,2523,6203,2333,0152,3761,524548
Total liabilities:9,7689,8577,0935,3494,6673,5581,668
Stockholders' equity
Stockholders' equity attributable to parent, including:17,72216,29414,19912,1409,95821,1756,044
Common stock54494135272619
Additional paid in capital154,731126,526103,85485,60465,77562,28735,149
Accumulated other comprehensive income (loss)148(60)126224(129)(193)(84)
Accumulated deficit(136,989)(110,174)(89,822)(73,723)(55,714)(40,945) 
Other undisclosed stockholders' equity attributable to parent(222)(47)    (29,040)
Stockholders' equity attributable to noncontrolling interest(222)      
Other undisclosed stockholders' equity22247     
Total stockholders' equity:17,72216,34114,19912,1409,95821,1756,044
Other undisclosed liabilities and equity (47)     
TOTAL LIABILITIES AND EQUITY:27,49026,15121,29117,48914,62424,7337,712

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues901317 350  
Loss on disposition of assets for financial service operations(26)   
Other income    350  
Cost of revenue
(Cost of Goods and Services Sold)
 (800)     
Gross profit:90(787)17 350  
Operating expenses(28,423)(21,261)(16,060)(17,898)(15,046)(12,267)(10,006)
Other undisclosed operating income (loss) 800  (350)  
Operating loss:(28,333)(21,248)(16,043)(17,898)(15,046)(12,267)(10,006)
Nonoperating income (expense)1,343849(56)   (16)
Other nonoperating income (expense)  197   (16)
Interest and debt expense(156)(130)127(111)(73)  
Loss from continuing operations before income taxes:(27,146)(20,529)(15,972)(18,009)(15,119)(12,267)(10,021)
Income tax expense      (5)
Other undisclosed income from continuing operations331177     
Loss before gain (loss) on sale of properties:(26,815)(20,352)(15,972)(18,009)(15,119)(12,267)(10,026)
Other undisclosed net loss(175) (127)    
Net loss:(26,990)(20,352)(16,099)(18,009)(15,119)(12,267)(10,026)
Other undisclosed net income (loss) attributable to parent (47)  350361496
Net loss available to common stockholders, diluted:(26,990)(20,399)(16,099)(18,009)(14,769)(11,905)(9,530)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(26,990)(20,352)(16,099)(18,009)(15,119)(12,267)(10,026)
Other comprehensive income (loss)(26,781)(20,585)(16,197) 64(109)20
Comprehensive loss:(53,771)(40,937)(32,296)(18,009)(15,055)(12,376)(10,006)
Other undisclosed comprehensive income, net of tax, attributable to parent   353350361496
Comprehensive loss, net of tax, attributable to parent:(53,771)(40,937)(32,296)(17,656)(14,705)(12,014)(9,511)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: